Medicare GLP-1 Bridge Questions & Answers

by OCAN

This document is a comprehensive Questions & Answers guide created by the Obesity Care Advocacy Network (OCAN) detailing the upcoming Medicare GLP-1 Bridge program. Starting July 1, 2026, this landmark initiative will bypass the traditional Medicare Part D system to provide eligible beneficiaries with direct, affordable access to covered obesity medications for a flat $50/month.

The guide acts as an operational roadmap, breaking down exactly how the program functions outside of standard Part D coverage, listing the specific clinical eligibility criteria, and outlining the specialized prescribing, prior authorization, and pharmacy routing workflows required to secure coverage.

Illustration of a bridge labeled "Medicare GLP-1," symbolizing access to diabetes medication coverage.
Previous
Previous

Medicare GLP-1 Bridge: The Patient Journey Roadmap

Next
Next

Federal Expansion of Obesity Medications through Medicare and Medicaid Fact Sheet